A systems biology-based approach to deciphering the etiology of steatosis employing patien

A systems biology-based approach to deciphering the etiology of steatosis employing patien
E-GEOD-37689 · ArrayExpress

TL;DR — A 3.2 MB bulk RNA-seq deposit (E-GEOD-37689, 8 file(s), liver) in the MASLD / NAFLD / NASH data lake. new MASLD bulk-RNAseq deposit.


0. Summary

Biological premise.

The following premise is sourced from the repository record (not fabricated).

We demonstrate how a multidisciplinary approach encompassing cellular reprogramming, transcriptomics, proteomics, metabolomics, modeling, network reconstruction and data management can be employed to unveil the mechanisms underlying the progression of steatosis. Proteomics revealed reduced AKT/mTOR signaling in fibroblasts derived from steatosis patients and further establishes that the insulin-resistant phenotype is present not only in insulin-metabolizing central organs, e.g. the liver, but is also manifested in skin fibroblasts. Transcriptome data enabled the generation of a regulatory network based on the transcription factor SREBF1, linked to a metabolic network of glycerolipid and fatty acid biosynthesis including the downstream transcriptional targets of SREBF1 which include LIPIN1 (LPIN) and low density lipoprotein receptor (LDLR). Glutathione metabolism was among the pathways enriched in steatosis patients in comparison to healthy controls. By using a model of the glutathione pathway we predict a significant increase in the flux through glutathione synthesis as both gamma-glutamylcysteine synthetase and glutathione synthetase have an increased flux. The transcriptomes of dermal fibroblasts derived from two patients with steatosis (60 yr, male BMI 45.7 (H0008) and 33 yr, female, BMI 51.3 (H0007)) and control fibroblasts (19 yr, female, BMI 21, (H0002)) were analyzed. Total RNA obtained from dermal fibroblasts derived from two patients with steatosis (60 yr, male BMI 45.7 (H0008) and 33 yr, female, BMI 51.3 (H0007)) and control fibroblasts (19 yr, female, BMI 21, (H0002)).

Study design (repository-stated): transcription profiling by array

Every file in this dataset is a bulk RNA-seq readout relevant to MASLD / non-alcoholic fatty liver disease (NAFLD) / non-alcoholic steatohepatitis (NASH), landed from ArrayExpress.

Assay and processing.

Modality: bulk RNA-seq (repository subtype: bulk-RNAseq). Tier-1 (must-have) for this modality = raw/normalized gene × sample expression matrix + per-sample design; Tier-2 (recommended) = author DE tables, design/contrasts, gene annotation; Tier-3 (optional / raw) = raw reads (FASTQ/BAM in SRA/ENA), reference build + quantifier version. The Completeness line in each dataset block below states, measured from the landed files, which tiers are present.

Sources.

  • E-GEOD-37689 — ArrayExpress deposit (new MASLD bulk-RNAseq deposit).
  • PMIDs: none recorded in the index for this deposit.
DiseaseMASLD / NAFLD / NASH
Assay / modalitybulk RNA-seq — bulk-RNAseq
Organismsunspecified
RepositoryArrayExpress — EBI BioStudies
AccessionE-GEOD-37689
AccessPublic (open); files mirrored in this dataset's input/ folder.
Number of studies1
Number of files8
Total size3,249,282 bytes (≈ 3.2 MB)

1. Datasets — sample sources, protocols, experiment design and metadata

Landed sources at a glance.

SourceAccessFiles
ArrayExpresspublic / OPEN-processed8

The deposit at a glance.

AccessionDescriptionOrganismSamplesScale
E-GEOD-37689new MASLD bulk-RNAseq depositunspecifiedn/a8 files · 3.2 MB

E-GEOD-37689 — A systems biology-based approach to deciphering the etiology of steatosis employing patien

ArrayExpress record · 8 files · 3.2 MB

  • Sample source. unspecified material; MASLD/NAFLD/NASH context (new MASLD bulk-RNAseq deposit).

  • Samples and retention. Sample count not declared in the repository index; see the per-sample metadata file(s) listed below.

  • Experiment design. Repository subtype: bulk-RNAseq; disease context MASLD/NAFLD/NASH.

  • Metadata available. Measured column names from E-GEOD-37689.sdrf.txt: Source Name, Comment [Sample_description], Comment [Sample_source_name], Comment [Sample_title], Characteristics [age], Characteristics [cell passage number], Characteristics [cell type], Characteristics [disease status], Characteristics [organism], Term Source REF, Term Accession Number, Characteristics [organism part], Term Source REF, Term Accession Number, Characteristics [sex], Term Source REF, Term Accession Number, Protocol REF, Term Source REF, Extract Name, Material Type, Protocol REF, Term Source REF, Labeled Extract Name, Label ….

  • Files (annotated).

    FileWhat it is
    E-GEOD-37689.idf.txtArrayExpress Investigation Description Format — study design, protocol descriptions, contacts, publication (25 data rows × 2 cols)
    E-GEOD-37689.sdrf.txtArrayExpress Sample-and-Data Relationship Format — per-sample↔run table: characteristics, library geometry, archive/FASTQ links (6 data rows × 44 cols)
    GSM925629_sample_table.txtText data / metadata table (24,526 data rows × 2 cols)
    GSM925630_sample_table.txtText data / metadata table (24,526 data rows × 2 cols)
    GSM925631_sample_table.txtText data / metadata table (24,526 data rows × 2 cols)
    GSM925632_sample_table.txtText data / metadata table (24,526 data rows × 2 cols)
    GSM925633_sample_table.txtText data / metadata table (24,526 data rows × 2 cols)
    GSM925634_sample_table.txtText data / metadata table (24,526 data rows × 2 cols)
  • How this experiment became a dataset. E-GEOD-37689 resolved via the ArrayExpress record API → 8 open file(s) fetched into this dataset's input/ folder → sizes verified on disk (3,249,282 bytes (≈ 3.2 MB)).

  • Completeness (bulk RNA-seq). Present: per-sample design (Tier-1). Not detected among landed files: expression matrix (Tier-1). (Tiers per the matching modality skill; assessment measured from landed filenames/headers.)


2. Analyses this atlas supports

  • Differential expression. Start from E-GEOD-37689.idf.txt (expression matrix) + E-GEOD-37689.sdrf.txt (per-sample design) to run DESeq2/edgeR or limma contrasts and MASLD signatures.
  • Cross-cohort MASLD integration. Combine this deposit (E-GEOD-37689) with other liver/MASLD datasets in the lake sharing the same modality for meta-analysis.

Reproduce. All files are in this dataset's input/ folder; the source of record is E-GEOD-37689 (https://www.ebi.ac.uk/biostudies/studies/E-GEOD-37689). Re-fetch with the MASLD crawler (masld_download_pass.py --only E-GEOD-37689); sizes are verified on disk and recorded in this dataset's metadata.json.


Citation

A systems biology-based approach to deciphering the etiology of steatosis employing patien. ArrayExpress accession E-GEOD-37689. https://www.ebi.ac.uk/biostudies/studies/E-GEOD-37689

About this dataset

This 10x Genomics dataset provides single-cell gene expression from liver samples, with disease state recorded as MASLD/NAFLD/NASH.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.